Immunogenicity and protective efficacy of a live attenuated H5N1 vaccine in nonhuman primates.
Identifieur interne : 000236 ( PubMed/Corpus ); précédent : 000235; suivant : 000237Immunogenicity and protective efficacy of a live attenuated H5N1 vaccine in nonhuman primates.
Auteurs : Shufang Fan ; Yuwei Gao ; Kyoko Shinya ; Chris Kafai Li ; Yanbing Li ; Jianzhong Shi ; Yongping Jiang ; Yongbing Suo ; Tiegang Tong ; Gongxun Zhong ; Jiasheng Song ; Ying Zhang ; Guobin Tian ; Yuntao Guan ; Xiao-Ning Xu ; Zhigao Bu ; Yoshihiro Kawaoka ; Hualan ChenSource :
- PLoS pathogens [ 1553-7374 ] ; 2009.
English descriptors
- KwdEn :
- Administration, Intranasal, Animals, Antibodies, Viral (blood), Body Temperature, Female, Influenza A Virus, H5N1 Subtype (immunology), Influenza A Virus, H5N1 Subtype (physiology), Influenza Vaccines (immunology), Injections, Intravenous, Macaca mulatta, Mice, Mice, Inbred BALB C, Orthomyxoviridae Infections (prevention & control), Orthomyxoviridae Infections (virology), Reassortant Viruses (immunology), T-Lymphocytes (immunology), Vaccination, Vaccines, Attenuated (immunology), Viral Load, Virus Replication, Virus Shedding.
- MESH :
- chemical , blood : Antibodies, Viral.
- immunology : Influenza A Virus, H5N1 Subtype, Influenza Vaccines, Reassortant Viruses, T-Lymphocytes, Vaccines, Attenuated.
- physiology : Influenza A Virus, H5N1 Subtype.
- prevention & control : Orthomyxoviridae Infections.
- virology : Orthomyxoviridae Infections.
- Administration, Intranasal, Animals, Body Temperature, Female, Injections, Intravenous, Macaca mulatta, Mice, Mice, Inbred BALB C, Vaccination, Viral Load, Virus Replication, Virus Shedding.
Abstract
The continued spread of highly pathogenic H5N1 influenza viruses among poultry and wild birds, together with the emergence of drug-resistant variants and the possibility of human-to-human transmission, has spurred attempts to develop an effective vaccine. Inactivated subvirion or whole-virion H5N1 vaccines have shown promising immunogenicity in clinical trials, but their ability to elicit protective immunity in unprimed human populations remains unknown. A cold-adapted, live attenuated vaccine with the hemagglutinin (HA) and neuraminidase (NA) genes of an H5N1 virus A/VN/1203/2004 (clade 1) was protective against the pulmonary replication of homologous and heterologous wild-type H5N1 viruses in mice and ferrets. In this study, we used reverse genetics to produce a cold-adapted, live attenuated H5N1 vaccine (AH/AAca) that contains HA and NA genes from a recent H5N1 isolate, A/Anhui/2/05 virus (AH/05) (clade 2.3), and the backbone of the cold-adapted influenza H2N2 A/AnnArbor/6/60 virus (AAca). AH/AAca was attenuated in chickens, mice, and monkeys, and it induced robust neutralizing antibody responses as well as HA-specific CD4+ T cell immune responses in rhesus macaques immunized twice intranasally. Importantly, the vaccinated macaques were fully protected from challenge with either the homologous AH/05 virus or a heterologous H5N1 virus, A/bar-headed goose/Qinghai/3/05 (BHG/05; clade 2.2). These results demonstrate for the first time that a cold-adapted H5N1 vaccine can elicit protective immunity against highly pathogenic H5N1 virus infection in a nonhuman primate model and provide a compelling argument for further testing of double immunization with live attenuated H5N1 vaccines in human trials.
DOI: 10.1371/journal.ppat.1000409
PubMed: 19412338
Links to Exploration step
pubmed:19412338Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Immunogenicity and protective efficacy of a live attenuated H5N1 vaccine in nonhuman primates.</title><author><name sortKey="Fan, Shufang" sort="Fan, Shufang" uniqKey="Fan S" first="Shufang" last="Fan">Shufang Fan</name><affiliation><nlm:affiliation>Animal Influenza Laboratory of the Ministry of Agriculture and National Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, PR China.</nlm:affiliation></affiliation></author><author><name sortKey="Gao, Yuwei" sort="Gao, Yuwei" uniqKey="Gao Y" first="Yuwei" last="Gao">Yuwei Gao</name></author><author><name sortKey="Shinya, Kyoko" sort="Shinya, Kyoko" uniqKey="Shinya K" first="Kyoko" last="Shinya">Kyoko Shinya</name></author><author><name sortKey="Li, Chris Kafai" sort="Li, Chris Kafai" uniqKey="Li C" first="Chris Kafai" last="Li">Chris Kafai Li</name></author><author><name sortKey="Li, Yanbing" sort="Li, Yanbing" uniqKey="Li Y" first="Yanbing" last="Li">Yanbing Li</name></author><author><name sortKey="Shi, Jianzhong" sort="Shi, Jianzhong" uniqKey="Shi J" first="Jianzhong" last="Shi">Jianzhong Shi</name></author><author><name sortKey="Jiang, Yongping" sort="Jiang, Yongping" uniqKey="Jiang Y" first="Yongping" last="Jiang">Yongping Jiang</name></author><author><name sortKey="Suo, Yongbing" sort="Suo, Yongbing" uniqKey="Suo Y" first="Yongbing" last="Suo">Yongbing Suo</name></author><author><name sortKey="Tong, Tiegang" sort="Tong, Tiegang" uniqKey="Tong T" first="Tiegang" last="Tong">Tiegang Tong</name></author><author><name sortKey="Zhong, Gongxun" sort="Zhong, Gongxun" uniqKey="Zhong G" first="Gongxun" last="Zhong">Gongxun Zhong</name></author><author><name sortKey="Song, Jiasheng" sort="Song, Jiasheng" uniqKey="Song J" first="Jiasheng" last="Song">Jiasheng Song</name></author><author><name sortKey="Zhang, Ying" sort="Zhang, Ying" uniqKey="Zhang Y" first="Ying" last="Zhang">Ying Zhang</name></author><author><name sortKey="Tian, Guobin" sort="Tian, Guobin" uniqKey="Tian G" first="Guobin" last="Tian">Guobin Tian</name></author><author><name sortKey="Guan, Yuntao" sort="Guan, Yuntao" uniqKey="Guan Y" first="Yuntao" last="Guan">Yuntao Guan</name></author><author><name sortKey="Xu, Xiao Ning" sort="Xu, Xiao Ning" uniqKey="Xu X" first="Xiao-Ning" last="Xu">Xiao-Ning Xu</name></author><author><name sortKey="Bu, Zhigao" sort="Bu, Zhigao" uniqKey="Bu Z" first="Zhigao" last="Bu">Zhigao Bu</name></author><author><name sortKey="Kawaoka, Yoshihiro" sort="Kawaoka, Yoshihiro" uniqKey="Kawaoka Y" first="Yoshihiro" last="Kawaoka">Yoshihiro Kawaoka</name></author><author><name sortKey="Chen, Hualan" sort="Chen, Hualan" uniqKey="Chen H" first="Hualan" last="Chen">Hualan Chen</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2009">2009</date><idno type="RBID">pubmed:19412338</idno><idno type="pmid">19412338</idno><idno type="doi">10.1371/journal.ppat.1000409</idno><idno type="wicri:Area/PubMed/Corpus">000236</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000236</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Immunogenicity and protective efficacy of a live attenuated H5N1 vaccine in nonhuman primates.</title><author><name sortKey="Fan, Shufang" sort="Fan, Shufang" uniqKey="Fan S" first="Shufang" last="Fan">Shufang Fan</name><affiliation><nlm:affiliation>Animal Influenza Laboratory of the Ministry of Agriculture and National Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, PR China.</nlm:affiliation></affiliation></author><author><name sortKey="Gao, Yuwei" sort="Gao, Yuwei" uniqKey="Gao Y" first="Yuwei" last="Gao">Yuwei Gao</name></author><author><name sortKey="Shinya, Kyoko" sort="Shinya, Kyoko" uniqKey="Shinya K" first="Kyoko" last="Shinya">Kyoko Shinya</name></author><author><name sortKey="Li, Chris Kafai" sort="Li, Chris Kafai" uniqKey="Li C" first="Chris Kafai" last="Li">Chris Kafai Li</name></author><author><name sortKey="Li, Yanbing" sort="Li, Yanbing" uniqKey="Li Y" first="Yanbing" last="Li">Yanbing Li</name></author><author><name sortKey="Shi, Jianzhong" sort="Shi, Jianzhong" uniqKey="Shi J" first="Jianzhong" last="Shi">Jianzhong Shi</name></author><author><name sortKey="Jiang, Yongping" sort="Jiang, Yongping" uniqKey="Jiang Y" first="Yongping" last="Jiang">Yongping Jiang</name></author><author><name sortKey="Suo, Yongbing" sort="Suo, Yongbing" uniqKey="Suo Y" first="Yongbing" last="Suo">Yongbing Suo</name></author><author><name sortKey="Tong, Tiegang" sort="Tong, Tiegang" uniqKey="Tong T" first="Tiegang" last="Tong">Tiegang Tong</name></author><author><name sortKey="Zhong, Gongxun" sort="Zhong, Gongxun" uniqKey="Zhong G" first="Gongxun" last="Zhong">Gongxun Zhong</name></author><author><name sortKey="Song, Jiasheng" sort="Song, Jiasheng" uniqKey="Song J" first="Jiasheng" last="Song">Jiasheng Song</name></author><author><name sortKey="Zhang, Ying" sort="Zhang, Ying" uniqKey="Zhang Y" first="Ying" last="Zhang">Ying Zhang</name></author><author><name sortKey="Tian, Guobin" sort="Tian, Guobin" uniqKey="Tian G" first="Guobin" last="Tian">Guobin Tian</name></author><author><name sortKey="Guan, Yuntao" sort="Guan, Yuntao" uniqKey="Guan Y" first="Yuntao" last="Guan">Yuntao Guan</name></author><author><name sortKey="Xu, Xiao Ning" sort="Xu, Xiao Ning" uniqKey="Xu X" first="Xiao-Ning" last="Xu">Xiao-Ning Xu</name></author><author><name sortKey="Bu, Zhigao" sort="Bu, Zhigao" uniqKey="Bu Z" first="Zhigao" last="Bu">Zhigao Bu</name></author><author><name sortKey="Kawaoka, Yoshihiro" sort="Kawaoka, Yoshihiro" uniqKey="Kawaoka Y" first="Yoshihiro" last="Kawaoka">Yoshihiro Kawaoka</name></author><author><name sortKey="Chen, Hualan" sort="Chen, Hualan" uniqKey="Chen H" first="Hualan" last="Chen">Hualan Chen</name></author></analytic><series><title level="j">PLoS pathogens</title><idno type="eISSN">1553-7374</idno><imprint><date when="2009" type="published">2009</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Administration, Intranasal</term><term>Animals</term><term>Antibodies, Viral (blood)</term><term>Body Temperature</term><term>Female</term><term>Influenza A Virus, H5N1 Subtype (immunology)</term><term>Influenza A Virus, H5N1 Subtype (physiology)</term><term>Influenza Vaccines (immunology)</term><term>Injections, Intravenous</term><term>Macaca mulatta</term><term>Mice</term><term>Mice, Inbred BALB C</term><term>Orthomyxoviridae Infections (prevention & control)</term><term>Orthomyxoviridae Infections (virology)</term><term>Reassortant Viruses (immunology)</term><term>T-Lymphocytes (immunology)</term><term>Vaccination</term><term>Vaccines, Attenuated (immunology)</term><term>Viral Load</term><term>Virus Replication</term><term>Virus Shedding</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antibodies, Viral</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza A Virus, H5N1 Subtype</term><term>Influenza Vaccines</term><term>Reassortant Viruses</term><term>T-Lymphocytes</term><term>Vaccines, Attenuated</term></keywords><keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Influenza A Virus, H5N1 Subtype</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Orthomyxoviridae Infections</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Orthomyxoviridae Infections</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Administration, Intranasal</term><term>Animals</term><term>Body Temperature</term><term>Female</term><term>Injections, Intravenous</term><term>Macaca mulatta</term><term>Mice</term><term>Mice, Inbred BALB C</term><term>Vaccination</term><term>Viral Load</term><term>Virus Replication</term><term>Virus Shedding</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The continued spread of highly pathogenic H5N1 influenza viruses among poultry and wild birds, together with the emergence of drug-resistant variants and the possibility of human-to-human transmission, has spurred attempts to develop an effective vaccine. Inactivated subvirion or whole-virion H5N1 vaccines have shown promising immunogenicity in clinical trials, but their ability to elicit protective immunity in unprimed human populations remains unknown. A cold-adapted, live attenuated vaccine with the hemagglutinin (HA) and neuraminidase (NA) genes of an H5N1 virus A/VN/1203/2004 (clade 1) was protective against the pulmonary replication of homologous and heterologous wild-type H5N1 viruses in mice and ferrets. In this study, we used reverse genetics to produce a cold-adapted, live attenuated H5N1 vaccine (AH/AAca) that contains HA and NA genes from a recent H5N1 isolate, A/Anhui/2/05 virus (AH/05) (clade 2.3), and the backbone of the cold-adapted influenza H2N2 A/AnnArbor/6/60 virus (AAca). AH/AAca was attenuated in chickens, mice, and monkeys, and it induced robust neutralizing antibody responses as well as HA-specific CD4+ T cell immune responses in rhesus macaques immunized twice intranasally. Importantly, the vaccinated macaques were fully protected from challenge with either the homologous AH/05 virus or a heterologous H5N1 virus, A/bar-headed goose/Qinghai/3/05 (BHG/05; clade 2.2). These results demonstrate for the first time that a cold-adapted H5N1 vaccine can elicit protective immunity against highly pathogenic H5N1 virus infection in a nonhuman primate model and provide a compelling argument for further testing of double immunization with live attenuated H5N1 vaccines in human trials.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19412338</PMID><DateCompleted><Year>2009</Year><Month>08</Month><Day>26</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1553-7374</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>5</Issue><PubDate><Year>2009</Year><Month>May</Month></PubDate></JournalIssue><Title>PLoS pathogens</Title><ISOAbbreviation>PLoS Pathog.</ISOAbbreviation></Journal><ArticleTitle>Immunogenicity and protective efficacy of a live attenuated H5N1 vaccine in nonhuman primates.</ArticleTitle><Pagination><MedlinePgn>e1000409</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.ppat.1000409</ELocationID><Abstract><AbstractText>The continued spread of highly pathogenic H5N1 influenza viruses among poultry and wild birds, together with the emergence of drug-resistant variants and the possibility of human-to-human transmission, has spurred attempts to develop an effective vaccine. Inactivated subvirion or whole-virion H5N1 vaccines have shown promising immunogenicity in clinical trials, but their ability to elicit protective immunity in unprimed human populations remains unknown. A cold-adapted, live attenuated vaccine with the hemagglutinin (HA) and neuraminidase (NA) genes of an H5N1 virus A/VN/1203/2004 (clade 1) was protective against the pulmonary replication of homologous and heterologous wild-type H5N1 viruses in mice and ferrets. In this study, we used reverse genetics to produce a cold-adapted, live attenuated H5N1 vaccine (AH/AAca) that contains HA and NA genes from a recent H5N1 isolate, A/Anhui/2/05 virus (AH/05) (clade 2.3), and the backbone of the cold-adapted influenza H2N2 A/AnnArbor/6/60 virus (AAca). AH/AAca was attenuated in chickens, mice, and monkeys, and it induced robust neutralizing antibody responses as well as HA-specific CD4+ T cell immune responses in rhesus macaques immunized twice intranasally. Importantly, the vaccinated macaques were fully protected from challenge with either the homologous AH/05 virus or a heterologous H5N1 virus, A/bar-headed goose/Qinghai/3/05 (BHG/05; clade 2.2). These results demonstrate for the first time that a cold-adapted H5N1 vaccine can elicit protective immunity against highly pathogenic H5N1 virus infection in a nonhuman primate model and provide a compelling argument for further testing of double immunization with live attenuated H5N1 vaccines in human trials.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Shufang</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Animal Influenza Laboratory of the Ministry of Agriculture and National Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Yuwei</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Shinya</LastName><ForeName>Kyoko</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Chris Kafai</ForeName><Initials>CK</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yanbing</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Jianzhong</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Yongping</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Suo</LastName><ForeName>Yongbing</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Tong</LastName><ForeName>Tiegang</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Gongxun</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Jiasheng</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Ying</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Guobin</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Guan</LastName><ForeName>Yuntao</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Xiao-Ning</ForeName><Initials>XN</Initials></Author><Author ValidYN="Y"><LastName>Bu</LastName><ForeName>Zhigao</ForeName><Initials>Z</Initials></Author><Author ValidYN="Y"><LastName>Kawaoka</LastName><ForeName>Yoshihiro</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Hualan</ForeName><Initials>H</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MC_EX_G0700930</GrantID><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2009</Year><Month>05</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Pathog</MedlineTA><NlmUniqueID>101238921</NlmUniqueID><ISSNLinking>1553-7366</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014613">Vaccines, Attenuated</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000281" MajorTopicYN="N">Administration, Intranasal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001831" MajorTopicYN="N">Body Temperature</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053124" MajorTopicYN="N">Influenza A Virus, H5N1 Subtype</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007275" MajorTopicYN="N">Injections, Intravenous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008253" MajorTopicYN="N">Macaca mulatta</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009976" MajorTopicYN="N">Orthomyxoviridae Infections</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016865" MajorTopicYN="N">Reassortant Viruses</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013601" MajorTopicYN="N">T-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014613" MajorTopicYN="N">Vaccines, Attenuated</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019562" MajorTopicYN="N">Viral Load</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017201" MajorTopicYN="N">Virus Shedding</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2008</Year><Month>09</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2009</Year><Month>04</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>5</Month><Day>5</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>5</Month><Day>5</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>8</Month><Day>27</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19412338</ArticleId><ArticleId IdType="doi">10.1371/journal.ppat.1000409</ArticleId><ArticleId IdType="pmc">PMC2669169</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2000 May 23;97(11):6108-13</Citation><ArticleIdList><ArticleId IdType="pubmed">10801978</ArticleId></ArticleIdList></Reference><Reference><Citation>Viral Immunol. 2002;15(2):295-323</Citation><ArticleIdList><ArticleId IdType="pubmed">12081014</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 2003 Jan 5;305(1):192-200</Citation><ArticleIdList><ArticleId IdType="pubmed">12504552</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2003 Oct 1;21(27-30):4430-6</Citation><ArticleIdList><ArticleId IdType="pubmed">14505926</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2004 Jul 13;101(28):10452-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15235128</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 1985 Dec;3(5):355-69</Citation><ArticleIdList><ArticleId IdType="pubmed">3909681</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 1988 Dec;167(2):554-67</Citation><ArticleIdList><ArticleId IdType="pubmed">2974219</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1998 Jan 16;279(5349):393-6</Citation><ArticleIdList><ArticleId IdType="pubmed">9430591</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1998 Feb 14;351(9101):472-7</Citation><ArticleIdList><ArticleId IdType="pubmed">9482438</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 1998 Dec 20;252(2):331-42</Citation><ArticleIdList><ArticleId IdType="pubmed">9878612</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 1999 May;179(5):1132-8</Citation><ArticleIdList><ArticleId IdType="pubmed">10191214</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9345-50</Citation><ArticleIdList><ArticleId IdType="pubmed">10430945</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1999 Nov;73(11):9679-82</Citation><ArticleIdList><ArticleId IdType="pubmed">10516084</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2005 Jul;11(7):1036-41</Citation><ArticleIdList><ArticleId IdType="pubmed">16022777</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2005 Sep;79(18):12058-64</Citation><ArticleIdList><ArticleId IdType="pubmed">16140781</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2005 Oct 20;437(7062):1108</Citation><ArticleIdList><ArticleId IdType="pubmed">16228009</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2005 Dec 22;353(25):2667-72</Citation><ArticleIdList><ArticleId IdType="pubmed">16371632</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2006 Mar 30;354(13):1343-51</Citation><ArticleIdList><ArticleId IdType="pubmed">16571878</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2006 Mar 30;354(13):1421-2</Citation><ArticleIdList><ArticleId IdType="pubmed">16571888</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2006 Jun 15;193(12):1626-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16703504</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2006 May 20;367(9523):1657-64</Citation><ArticleIdList><ArticleId IdType="pubmed">16714186</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2006 Jun;80(12):5976-83</Citation><ArticleIdList><ArticleId IdType="pubmed">16731936</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2006 Sep 16;368(9540):991-7</Citation><ArticleIdList><ArticleId IdType="pubmed">16980114</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2006 Sep;3(9):e360</Citation><ArticleIdList><ArticleId IdType="pubmed">16968127</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2007 Feb 15;356(7):685-96</Citation><ArticleIdList><ArticleId IdType="pubmed">17301299</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Immunol. 2007 Apr;7(4):267-78</Citation><ArticleIdList><ArticleId IdType="pubmed">17363960</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2007 Nov;81(21):11560-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17715243</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2008 Jan 17;358(3):261-73</Citation><ArticleIdList><ArticleId IdType="pubmed">18199865</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2007 Jul;13(7):1061-4</Citation><ArticleIdList><ArticleId IdType="pubmed">18214180</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2008 Mar;82(5):2565-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18094159</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2008 Apr 26;371(9622):1464-75</Citation><ArticleIdList><ArticleId IdType="pubmed">18440429</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000236 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000236 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= H2N2V1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:19412338
|texte= Immunogenicity and protective efficacy of a live attenuated H5N1 vaccine in nonhuman primates.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:19412338" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a H2N2V1
| This area was generated with Dilib version V0.6.33. |  |